We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NBL
326
DELISTED
Noble Energy, Inc.
NBL
| $25.8M | 0.06% |
752,464
+24,428
| +3% | +$904K |
|
327
iShares Core US Aggregate Bond ETF
AGG
$138B
| $25.7M | 0.06% |
236,983
+150,225
| +173% | +$16.3M |
|
|
CTXS
328
DELISTED
Citrix Systems Inc
CTXS
| $25.7M | 0.06% |
308,163
-72,357
| -19% | -$5.64M |
|
329
Ball Corp
BALL
$17.5B
| $25.6M | 0.06% |
690,066
+18,602
| +3% | +$694K |
|
|
NLSN
330
DELISTED
Nielsen Holdings plc
NLSN
| $25.6M | 0.06% |
619,553
+16,467
| +3% | +$705K |
|
331
Verisk Analytics
VRSK
$27.9B
| $25.6M | 0.06% |
314,895
+16,921
| +6% | +$1.39M |
|
332
Chipotle Mexican Grill
CMG
$43.9B
| $25.5M | 0.06% |
2,859,400
+18,950
| +0.7% | +$156K |
|
333
Entergy
ETR
$50.3B
| $25.4M | 0.06% |
667,532
+16,460
| +3% | +$603K |
|
334
C.H. Robinson
CHRW
$20.5B
| $25.3M | 0.06% |
327,849
+8,061
| +3% | +$619K |
|
335
International Flavors & Fragrances
IFF
$20.3B
| $25M | 0.06% |
188,631
+24,297
| +15% | +$2.98M |
|
|
GGP
336
DELISTED
GGP Inc.
GGP
| $25M | 0.06% |
1,078,291
+53,525
| +5% | +$1.31M |
|
|
CMA
337
DELISTED
Comerica
CMA
| $24.8M | 0.06% |
361,984
+12,265
| +4% | +$856K |
|
338
Loews
L
$24.5B
| $24.6M | 0.06% |
526,496
+15,994
| +3% | +$748K |
|
339
Everest Group
EG
$15.6B
| $24.6M | 0.06% |
105,274
+14,692
| +16% | +$3.36M |
|
340
Ameren
AEE
$30.4B
| $24.6M | 0.06% |
450,703
+11,239
| +3% | +$602K |
|
341
Campbell Soup
CPB
$6.85B
| $24.6M | 0.06% |
429,706
+6,177
| +1% | +$374K |
|
342
FirstEnergy
FE
$28.4B
| $24.3M | 0.06% |
762,990
+34,500
| +5% | +$1.06M |
|
|
HES
343
DELISTED
Hess
HES
| $24.2M | 0.06% |
502,481
+19,423
| +4% | +$1.03M |
|
344
L3Harris
LHX
$55.4B
| $24.1M | 0.06% |
216,580
+8,356
| +4% | +$894K |
|
345
Expeditors International
EXPD
$22.3B
| $24.1M | 0.06% |
425,742
+14,156
| +3% | +$776K |
|
346
Global Payments
GPN
$24.1B
| $24M | 0.06% |
297,211
+6,005
| +2% | +$471K |
|
347
Hasbro
HAS
$13.5B
| $23.9M | 0.06% |
239,062
+12,107
| +5% | +$1.12M |
|
|
TFCF
348
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $23.6M | 0.06% |
741,469
+12,320
| +2% | +$370K |
|
|
MRO
349
DELISTED
Marathon Oil Corporation
MRO
| $23.2M | 0.05% |
1,468,563
+48,945
| +3% | +$803K |
|
350
Cintas
CTAS
$86.6B
| $23.1M | 0.05% |
730,080
+49,348
| +7% | +$1.46M |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.